Charles River Laboratories International, Inc. (CRL)
Q2 2012 Earnings Results Conference
August 8, 2012 08:30 AM ET
James C. Foster - Chairman, CEO, President and Member of Strategic Planning & Capital Allocation Committee
Thomas F. Ackerman - CFO and Corporate EVP
Susan E. Hardy - Corporate Vice President of Investor Relations
Ross Muken - ISI Group Inc., Research Division
David Windley - Jefferies & Company, Inc., Research Division
Garen Sarafian - Citigroup Inc, Research Division
Timothy Evans - Wells Fargo Securities, LLC, Research Division
Douglas Schenkel - Cowen and Company, LLC, Research Division
Tycho Peterson - JP Morgan Chase & Co, Research Division
Gregory Bolan - Sterne Agee & Leach Inc., Research Division
Ricky Goldwasser - Morgan Stanley, Research Division
John Kreger - William Blair & Company L.L.C., Research Division
Ladies and gentlemen, thank you for standing by and welcome to the Charles River Laboratories Second Quarter 2012 Earnings Call and Meeting with Management. At this time, all participants are in a listen-only mode. Later, we will conduct the question-and-answer session. Instructions will be given to you at that time. (Operator Instructions) And as a reminder, today’s conference call is being recorded.
I’d now like to turn the conference over to Susan Hardy, Corporate Vice President of Investor Relations. Please go ahead.
Susan E. Hardy
Thank you. Good morning and welcome to Charles River Laboratories’ Second Quarter 2012 Conference Call and Webcast. This morning, Jim Foster, Chairman, President and Chief Executive Officer; and Tom Ackerman, Executive Vice President and Chief Financial Officer, will comment on our second quarter results and review guidance for 2012. Following their presentations, we will respond to questions.